Consumption and cost trends of EGFR TKIs: influences of reimbursement and national price negotiation.
Di WuJianxiang XieHuizhen DaiWentong FangPublished in: BMC health services research (2022)
The consumption of EGFT TKIs has increased and the DDC of EGFR TKIs has decreased since 2016. These trends may be attributed to drug reimbursement, price negotiation and generic drug replacement. Further efforts are needed to translate the high consumption of EGFR TKIs into clinical benefits.